ArticleFrontiers in oncology2026
Reconfiguring robotic surgery in head and neck practice: transition from multi-port to single-port with early clinical outcomes.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Institutional evolution of a robotic otolaryngology program across consecutive da Vinci Si, Xi, and SP platform transitions.Journal of robotic surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The integration of the da Vinci single-port (SP) platform into head and neck practice represents a major transition from conventional multi-port robotic systems, yet real-world data on early institutional adoption remain limited. This study evaluated the clinical integration of the SP platform during an early implementation period, with particular focus on case accrual, diversification of surgical access routes, surgeon-specific adoption patterns, and temporal evolution of case selection. Methods: This retrospective observational study included consecutive robotic head and neck procedures performed with the da Vinci SP system at a single institution during a 9-month transition period prior to the installation of a second SP system. Clinical, operative, and perioperative variables were extracted from an amended institutional dataset and operative records. Cases were analyzed overall, compared between the 2 primary surgeons, and chronologically stratified into Early and Later phases. Results: A total of 64 cases were performed, including 34 malignant (53.1%) and 30 benign (46.9%) lesions. Case accrual increased steadily throughout the study period. Transoral surgery was the most common access route (42/64, 65.6%), followed by transoral plus transcervical (12/64, 18.8%), transcervical alone (5/64, 7.8%), and retroauricular access (5/64, 7.8%). Surgeon 1 performed 51 cases and treated an older population with significantly higher rates of tobacco, alcohol, and betel quid exposure, more malignant disease, and broader anatomic distribution. Surgeon 2 performed 13 cases, all through a transoral approach, predominantly for benign lesions. A chronological comparison between the Early and Later phases showed stable surgeon distribution, pathology patterns, and approach patterns, but oral cavity cases and reconstructive procedures became more prominent in the Later phase. Cumulative accrual curves for benign and malignant disease progressed in parallel, suggesting that SP adoption expanded across both oncologic and benign indications rather than being confined to a single clinical niche. Conclusion: Early institutional integration of the da Vinci SP platform was associated with steady case accrual, expansion of operative access pathways, and broad adoption across malignant and benign head and neck indications. These findings provide real-world evidence that transition from multi-port to single-port robotic surgery can be achieved successfully within a high-volume head and neck program.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.